Downloads

Title
Supernus Pharmaceuticals Reports First Quarter 2013 Financial Results
Supernus Announces Closing of $90 Million of 7.50% Convertible Senior Secured Notes Due 2019
Supernus Announces First Quarter 2013 Earnings Conference Call and Webcast
Supernus Prices Offering of $75 Million of 7.50% Convertible Senior Secured Notes Due 2019
Supernus Announces Proposed Offering of $75 Million of Convertible Senior Secured Notes
2012 Annual Report
Supernus Pharmaceuticals Reports Fourth Quarter 2012 and Full Year 2012 Financial Results
Supernus Announces Year-End and Fourth Quarter 2012 Earnings Conference Call and Webcast
Supernus Launches Oxtellar XR(TM) in the United States
Supernus Appoints Victor Vaughn as Senior Vice President of Sales